Float Short %

22.89

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

-0.93

EPS Last/This Y

0.36

EPS This/Next Y

-0.34

Price

4.18

Target Price

20.14

Analyst Recom

1.67

Performance Q

6.62

Relative Volume

1.79

Beta

0.08

Ticker: ALT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	ALT	5.5	0.26	0.46	249690
2025-12-10	ALT	5.43	0.27	0.80	256957
2025-12-11	ALT	5.32	0.28	0.96	262955
2025-12-12	ALT	5.26	0.29	0.64	263401
2025-12-15	ALT	5.26	0.31	1.01	261716
2025-12-16	ALT	5.01	0.32	0.92	267873
2025-12-17	ALT	5.08	0.32	0.83	273258
2025-12-18	ALT	5.03	0.32	0.86	276081
2025-12-19	ALT	3.88	0.32	0.80	277376
2025-12-22	ALT	4.14	0.35	0.36	219045
2025-12-23	ALT	3.99	0.34	0.12	225445
2025-12-26	ALT	3.87	0.32	0.59	229130
2025-12-29	ALT	3.71	0.31	0.16	217596
2025-12-30	ALT	3.6	0.30	0.11	220216
2025-12-31	ALT	3.61	0.28	0.10	227012
2026-01-02	ALT	3.52	0.27	0.08	229554
2026-01-05	ALT	4.09	0.23	0.09	219046
2026-01-06	ALT	3.95	0.22	0.12	226985
2026-01-07	ALT	4.17	0.22	0.12	230207
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	ALT	5.52	24.7	-83.3	-0.99
2025-12-10	ALT	5.43	24.7	-82.3	-0.99
2025-12-11	ALT	5.33	24.7	-82.6	-0.99
2025-12-12	ALT	5.26	24.7	-83.4	-0.99
2025-12-15	ALT	5.28	24.7	-87.3	-0.99
2025-12-16	ALT	5.28	24.7	-87.8	-0.99
2025-12-17	ALT	5.09	24.7	-90.9	-0.99
2025-12-18	ALT	5.04	24.7	-84.5	-0.99
2025-12-19	ALT	3.88	24.7	-24.8	-0.99
2025-12-22	ALT	4.14	24.7	-106.4	-0.99
2025-12-23	ALT	3.99	24.7	-75.8	-0.98
2025-12-26	ALT	3.87	26.4	-78.3	-0.98
2025-12-29	ALT	3.68	26.4	-71.5	-0.98
2025-12-30	ALT	3.60	26.4	-79.1	-0.98
2025-12-31	ALT	3.61	26.4	-86.4	-0.98
2026-01-02	ALT	3.51	26.4	-77.2	-0.98
2026-01-05	ALT	4.09	26.4	-147.6	-0.98
2026-01-06	ALT	3.95	26.4	-76.1	-0.98
2026-01-07	ALT	4.18	26.4	-106.6	-0.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	ALT	0.00	3.96	22.50
2025-12-10	ALT	0.00	3.96	22.37
2025-12-11	ALT	0.00	3.96	22.37
2025-12-12	ALT	0.00	3.96	22.37
2025-12-15	ALT	0.00	3.96	22.35
2025-12-16	ALT	0.00	3.96	22.35
2025-12-17	ALT	0.00	3.96	22.35
2025-12-18	ALT	0.00	3.96	22.35
2025-12-19	ALT	0.00	3.96	22.35
2025-12-22	ALT	0.00	3.96	22.35
2025-12-23	ALT	1.79	3.96	22.35
2025-12-26	ALT	3.65	3.96	22.89
2025-12-29	ALT	3.65	3.95	22.89
2025-12-30	ALT	3.57	3.95	22.89
2025-12-31	ALT	3.57	3.95	22.89
2026-01-02	ALT	3.57	3.95	22.89
2026-01-05	ALT	3.64	3.96	22.89
2026-01-06	ALT	3.64	3.96	22.89
2026-01-07	ALT	3.64	3.96	22.89
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.26

Insider Transactions

3.64

Institutional Transactions

3.96

Beta

0.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-91.2

Target Price

20.14

P/E

Forward P/E

PEG

P/S

21859.95

P/B

2.16

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y

-0.98

EPS Next Y. (Est.)

-1.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-419575

Relative Volume

1.79

Return on Equity vs Sector %

-72.3

Return on Equity vs Industry %

-57.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

-106.6

Altimmune, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 59

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

stock quote shares ALT – Altimmune, Inc. Stock Price stock today

news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALT – Altimmune, Inc. yahoo finance google finance

stock history ALT – Altimmune, Inc. invest stock market

stock prices ALT premarket after hours

ticker ALT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ALT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y